Wells Fargo & Company Puma Biotechnology, Inc. Transaction History

Wells Fargo & Company

$433 Billion
Q4 2024

A detailed history of Wells Fargo & Company transactions in Puma Biotechnology, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 22,929 shares of PBYI stock, worth $66,035. This represents 0.0% of its overall portfolio holdings.

Number of Shares

22,929

Previous 16,803 36.46%

Holding current value

$66,035

Previous $42,000 64.29%

% of portfolio

0.0%

Previous 0.0%

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 12, 2025	BUY	$2.42 - $3.39 $14,824 - $20,767	6,126 Added 36.46%	22,929 $69,000
Q3 2024 Nov 13, 2024	BUY	$2.25 - $4.03 $794 - $1,422	353 Added 2.15%	16,803 $42,000
Q2 2024 Aug 13, 2024	BUY	$2.92 - $5.83 $23,751 - $47,421	8,134 Added 97.81%	16,450 $53,000
Q1 2024 May 10, 2024	BUY	$4.29 - $7.4 $34,341 - $59,237	8,005 Added 2573.95%	8,316 $44,000
Q4 2023 Feb 09, 2024	BUY	$2.23 - $4.49 $35 - $71	16 Added 5.42%	311 $1,000
Q3 2023 Nov 13, 2023	BUY	$2.63 - $4.09 $15 - $24	6 Added 2.08%	295 $0
Q2 2023 Aug 15, 2023	BUY	$2.6 - $3.58 $44 - $60	17 Added 6.25%	289 $1,000
Q1 2023 May 12, 2023	BUY	$2.21 - $4.82 $11 - $24	5 Added 1.87%	272 $0
Q4 2022 Feb 13, 2023	BUY	$2.12 - $5.08 $14 - $35	7 Added 2.69%	267 $1,000
Q3 2022 Nov 14, 2022	BUY	$2.27 - $3.84 $15 - $26	7 Added 2.77%	260 $1,000
Q2 2022 Aug 12, 2022	SELL	$1.64 - $3.3 $229,996 - $462,798	-140,242 Reduced 99.82%	253 $1,000
Q1 2022 May 16, 2022	SELL	$2.13 - $3.24 $160,331 - $243,884	-75,273 Reduced 34.89%	140,495 $404,000
Q4 2021 Feb 14, 2022	SELL	$2.85 - $6.58 $117,582 - $271,471	-41,257 Reduced 16.05%	215,768 $656,000
Q3 2021 Nov 15, 2021	BUY	$6.63 - $9.39 $215,839 - $305,691	32,555 Added 14.5%	257,025 $1.8 Million
Q2 2021 Aug 16, 2021	BUY	$8.98 - $11.6 $56,699 - $73,242	6,314 Added 2.89%	224,470 $2.06 Million
Q1 2021 May 13, 2021	BUY	$9.38 - $13.63 $1.29 Million - $1.87 Million	137,016 Added 168.86%	218,156 $2.12 Million
Q4 2020 Feb 09, 2021	SELL	$7.78 - $12.13 $161,419 - $251,673	-20,748 Reduced 20.36%	81,140 $833,000
Q3 2020 Nov 05, 2020	BUY	$9.5 - $11.14 $98,648 - $115,677	10,384 Added 11.35%	101,888 $1.03 Million
Q2 2020 Aug 13, 2020	BUY	$7.01 - $13.24 $3,056 - $5,772	436 Added 0.48%	91,504 $955,000
Q1 2020 May 14, 2020	BUY	$6.28 - $14.57 $571,907 - $1.33 Million	91,068 New	91,068 $768,000

Others Institutions Holding PBYI

# of Institutions

110

Shares Held

28.3M

Call Options Held

27.9K

Put Options Held

3.4K

View Full List

About PUMA BIOTECHNOLOGY, INC.

Ticker PBYI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 45,556,000
Market Cap $131M
Description
Puma Biotechnology, Inc., a biopharmaceutical company, focuses on the development and commercialization of products to enhance cancer care in the United States and internationally. The company's drug candidates include PB272 neratinib (oral) for the patients with early stage HER2-overexpressed/amplified breast cancer; PB272 (neratinib, oral) for...

More about PBYI

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Puma Biotechnology, Inc. Transaction History